Literature DB >> 3445297

Semen analyses in Hansen's disease.

D S Sheriff1.   

Abstract

Disturbances in semen quality can be induced by exogenous factors including trivial illnesses like throat infection and viral infection with fever. Hansen's disease presents with problems such as long term dependence on drugs, hyperthermia, haemolysis and anxiety due to social stigma. In the present study the semen quality of patients with tuberculoid-type leprosy was studied during and after withdrawal of therapy. Patients generally had low sperm counts and spermatozoal motility was low with a greater number of abnormal forms compared with control subjects. Patients did not show a circannual variation in their sperm count as was observed in controls. The patients were oligozoospermic during their first year of medication, showing improvement in subsequent years.

Entities:  

Mesh:

Year:  1987        PMID: 3445297     DOI: 10.1016/0035-9203(87)90299-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

Review 1.  The Disappearing Sperms: Analysis of Reports Published Between 1980 and 2015.

Authors:  Pallav Sengupta; Sulagna Dutta; Elzbieta Krajewska-Kulak
Journal:  Am J Mens Health       Date:  2016-04-19

Review 2.  Evidence for decreasing sperm count in African population from 1965 to 2015.

Authors:  Pallav Sengupta; Uchenna Nwagha; Sulagna Dutta; Elzbieta Krajewska-Kulak; Emmanuel Izuka
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

3.  The question of declining sperm density revisited: an analysis of 101 studies published 1934-1996.

Authors:  S H Swan; E P Elkin; L Fenster
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

Review 4.  An Assessment of Men Semen Alterations in SARS-CoV-2: Is Fever the Principal Concern?

Authors:  Mohamed Hadi Mohamed Abdelhamid; Abdulmunam A Fellah; Ahmed Elmarghani; Iman Amin Al Msellati
Journal:  Reprod Sci       Date:  2022-02-22       Impact factor: 3.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.